3-D Matrix (DMTRF) AI Stock Analysis

3-D Matrix

(Other OTC:DMTRF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue growthRapid and accelerating revenue growth indicates expanding commercialization of the company’s medical technology across its target markets. If sustained, a larger revenue base can improve operating leverage, support investment in product adoption, and provide a stronger foundation for durable earnings growth over the next several quarters.

Negative Factors

Weak cash conversionWeak conversion of accounting profit into operating and free cash flow raises questions about the quality and repeatability of reported earnings. Continued cash generation will be important because small cash surpluses and a history of substantial burn could constrain reinvestment and increase the need for external funding.

3-D Matrix (DMTRF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $310.35M
Dividend Yield: ―
Average Volume (3M): 2,051
Price to Earnings (P/E): 11.3
Beta (1Y): 0.09
Revenue Growth: 48.40%
EPS Growth: ―
Country: US
Employees: 129
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

3-D Matrix Business Overview & Revenue Model

Company Description

3-D Matrix, Ltd. specializes in pioneering self-assembling peptide technology. Its flagship product, PuraMatrix, is an innovative self-assembling peptide hydrogel with diverse applications across medical fields, including regenerative medicine, cell...

3-D Matrix Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DMTRF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:6678	82Outperform	JPY 18.42B	12.22	―	5.97%	20.88%	44.61%
JP:7963	64Neutral	JPY 8.49B	9.97	―	2.90%	9.02%	8.88%
JP:6523	58Neutral	JPY 180.17B	19.39	5.76%	2.99%	3.04%	-19.26%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
JP:4549	50Neutral	JPY 76.06B	39.82	―	2.59%	3.92%	-52.01%
JP:6849	46Neutral	JPY 265.01B	18.99	―	2.01%	1.43%	1.86%

* Healthcare Sector Average

Performance Comparison

DMTRF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DMTRF	3-D Matrix	2.42	0.92	61.67%
JP:6523	PHC Holdings Corp.	1405.00	412.43	41.55%
JP:4549	Eiken Chemical Co., Ltd.	2238.00	-95.34	-4.09%
JP:6678	Techno Medica Co., Ltd.	2161.00	334.37	18.31%
JP:6849	Nihon Kohden Corporation	1589.50	-157.88	-9.04%
JP:7963	Koken Ltd.	1705.00	-118.08	-6.48%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

3-D Matrix AI Stock Analysis